Wang Yi, Qin Qiyu, Liu Bo, Fu Yana, Lin Lin, Huang Xiaodan, Jin Xiuming
Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Front Med (Lausanne). 2019 Dec 10;6:291. doi: 10.3389/fmed.2019.00291. eCollection 2019.
To examine the time course of aqueous-deficient and meibomian gland dysfunction (MGD) in patients with primary Sjogren's Syndrome (pSS). This prospective study was conducted on pSS female patients in the Department of Rheumatism of the Second Affiliated Hospital, School of Medicine, Zhejiang University. The age-matched MGD female patients without pSS (non-SS-MGD) were recruited as MGD controls from the Eye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University. After providing written informed consent, the patients underwent an eye examination and completed an Ocular Surface Disease Index questionnaire that assessed the symptoms of dry eye disease. The subjects were evaluated using Schirmer I test (SIt), tear meniscus height (TMH), noninvasive keratographic break-up time (NIKBUT), corneal fluorescein staining (CFS), and meibomian gland evaluation (meibomian gland infrared, lid margin score, expressible meibomian glands number and the secretions quality). The patients were divided into two groups: early stage (≤3 years) and late stage (>3 years) according to their medical history of dry eye. The data were analyzed using SPSS 20.0. There were 49 pSS and 52 non-SS-MGD female patients enrolled in this study from 1 January 2018 to 30 December 2018. There were no differences in age (49.38 ± 10.32 and 48.69 ± 13.57 years) and dry eye medical history (48.44 ± 40.16 and 47.79 ± 37.85 months) between the two groups. When the medical history was ≤3 years, the average SIt and TMH of the pSS patients were significantly smaller than those of the patients with MGD. However, the signs related to the MGD did not show a significant difference between the two groups. When the medical history was >3 years, both the SIt and TMH and the signs related to MGD in pSS group were significantly more severe than the MGD group. Our results demonstrated that 3 years may be an important time node for the dry eye development in pSS patients, before this, the lacrimal glands received a greater influence, and then the meibomian glands began to be greatly affected.
为研究原发性干燥综合征(pSS)患者中水样液缺乏和睑板腺功能障碍(MGD)的时间进程。本前瞻性研究在浙江大学医学院附属第二医院风湿免疫科的pSS女性患者中开展。年龄匹配的无pSS的MGD女性患者(非SS-MGD)从浙江大学医学院附属第二医院眼科中心招募作为MGD对照。在提供书面知情同意后,患者接受眼部检查并完成一份评估干眼症状的眼表疾病指数问卷。使用泪液分泌试验I(SIt)、泪河高度(TMH)、非侵入性角膜表面泪膜破裂时间(NIKBUT)、角膜荧光素染色(CFS)和睑板腺评估(睑板腺红外成像、睑缘评分、可挤压睑板腺数量及分泌物质量)对受试者进行评估。根据干眼病史将患者分为两组:早期(≤3年)和晚期(>3年)。使用SPSS 20.0对数据进行分析。2018年1月1日至2018年12月31日,本研究共纳入49例pSS女性患者和52例非SS-MGD女性患者。两组患者在年龄(49.38±10.32岁和48.69±13.57岁)和干眼病史(48.44±40.16个月和47.79±37.85个月)方面无差异。当病史≤3年时,pSS患者的平均SIt和TMH显著低于MGD患者。然而,两组之间与MGD相关的体征无显著差异。当病史>3年时,pSS组的SIt和TMH以及与MGD相关的体征均显著比MGD组严重。我们的结果表明,3年可能是pSS患者干眼发展的一个重要时间节点,在此之前,泪腺受影响更大,之后睑板腺开始受到较大影响。